Find clinical trials for Asthma in Hanyang, Seoul
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Asthma trials near Hanyang, Seoul, KOR:
in patients ≥ 6 to \< 18 years of age with severe eosinophilic asthma, including a well-documented history of asthma exacerbations ...
Phase 3
Seoul, South Korea and 87 other locations
The purpose of this study is to evaluate the efficacy and safety of verekitug (UPB-101) in participants with severe asthma. The study will e...
Phase 2
Seoul, Korea, Republic of and 155 other locations
The purpose of this study is to evaluate dexpramipexole as an add-on oral therapy in participants with inadequately controlled eosinophilic asthma...
Phase 3
Seoul, South Korea and 335 other locations
To assess the efficacy and safety of tezepelumab in pediatric participants with severe uncontrolled asthma on medium to high-dose inhaled co...
Phase 3
Seoul, South Korea and 140 other locations
The primary objective of this study is to describe the efficacy of rocatinlimab in reducing asthma exacerbations....
Phase 2
Seoul, South Korea and 154 other locations
This is a study of amlitelimab for the treatment of participants with moderate-to-severe asthma. The study will have a double-blind treatmen...
Phase 2
Seoul, Seoul-teukbyeolsi, South Korea and 67 other locations
trifenatate (FF/UMEC/VI) with inhaled corticosteroids/long-acting beta-2 agonists (ICS/LABA) in adult participants with uncontrolled asthma...
Phase 4
Seoul, South Korea and 73 other locations
and safety of Atuliflapon administered once daily over a 12-week treatment period to adult participants with moderate to severe uncontrolled asthma...
Phase 2
Seoul, South Korea and 233 other locations
This is a phase 2, open-label extension study to evaluate the long-term safety and efficacy of lunsekimig in adult participants with asthma ...
Phase 2
Seoul, Seoul-teukbyeolsi, South Korea and 114 other locations
safety, and tolerability of add-on therapy with SC lunsekimig in adult participants aged 18 to 80 years, (inclusive) with moderate-to-severe asthma...
Phase 2
Seoul, Seoul-teukbyeolsi, Korea, Republic of and 162 other locations
Clinical trials
Research sites
Resources
Legal